Chordia President Confident in Success of “Synthetic Lethality” Drug; Negotiated Directly with Takeda to Establish Startup

Chordia President Hiroshi Miyake Hiroshi Miyake, president of Chordia Therapeutics, a biotech company established by a group of former researchers of Takeda Pharmaceutical, recently sat with Jiho to talk about the background of the establishment of the company. “I think...read more